covid 19 News and Research

RSS

Anti-CD20 therapy patients can develop immune responses after SARS-CoV-2 vaccination

A new systematic review and meta-analysis focused on the humoral and cell-mediated immune responses after COVID-19 vaccination in patients undergoing anti-CD20 antibodies treatment.

5 Oct 2021

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

Researchers from the University of Singapore have reviewed the data in post-vaccinated immunocompromised patients to examine the effectiveness of these vaccines in these patients.

5 Oct 2021

How accurate is COVID-19 modeling?

Researchers from the Burnet Institute in Melbourne have been using this to investigate how accurate COVID-19 modelling has been.

5 Oct 2021

The pandemic forced my transgender wife to fight our insurer over hormones

For the past eight years, my wife, Ky Hamilton, has undergone gender-affirming hormone therapy. As a transgender woman, she injects Depo-Estradiol liquid estrogen into her thigh once a week.

5 Oct 2021

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Your saliva may be able to tell you if you’ve developed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, suggests a new medRxiv* preprint study. In immunocompromised groups, salivary Immunoglobulin G (IgG) antibody levels were associated with IgG titers in blood serum 3 to 4 weeks after mRNA vaccination.

5 Oct 2021

Study suggests shingles vaccine reduces the risk for COVID-19

People who get the shingles vaccine may have a lower risk of being diagnosed and hospitalized with coronavirus disease 2019 (COVID-19), according to a new medRxiv* preprint study. In about 150,000 people over the age of 50, vaccination for shingles was associated with a 32% reduced risk of severe COVID-19 infection.

5 Oct 2021

Inflammatory molecules "trapped" inside micro clots may be the cause of Long COVID symptoms

New research indicates that an overload of various inflammatory molecules, literally "trapped" inside insoluble microscopic blood clots (micro clots), might be the cause of some of the lingering symptoms experienced by individuals with Long COVID.

5 Oct 2021

Study assesses Texas nurses' COVID-19 vaccination status, intention, and hesitancy

New research focused on Texas nurses has found predictors of a lack of intention to be vaccinated against COVID-19 includes previous COVID-19 infection, unfavorable vaccine attitudes, and concerns about vaccine safety.

5 Oct 2021

UD chemical engineer aims to improve the delivery of therapeutic medicines to the body

The human body has built-in protections to keep pathogens out. That sneezing fit or stuffy nose when you have a cold? That's your body leveraging mucosal linings in your respiratory system to expel the offending virus.

5 Oct 2021

New study underscores the importance of improving COVID-19 vaccination rates worldwide

Two doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six months, confirms a new study from Kaiser Permanente and Pfizer published in The Lancet.

5 Oct 2021

SARS-CoV-2 mRNA vaccines elicit higher levels of antibodies compared to natural infection

Researchers from the US recently characterized the scale and specificity of SARS-CoV-2 spike-reactive antibodies from 23 participants who received SARS-CoV-2 mRNA vaccines and 10 acutely infected health care workers. They found that primary mRNA vaccination and infection elicited S1- and S2-reactive antibodies, while secondary mRNA vaccination elicited mostly S1 antibodies.

4 Oct 2021

Is gout a risk factor for COVID-19?

A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.

4 Oct 2021

What makes SARS-CoV-2 variants more virulent?

Researchers in the Republic of Korea have conducted a study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – that could help to inform further studies investigating the increased virulence of variants of concern and interest.

4 Oct 2021

Scientists analyze if T-cell tests can be used to determine whether people had COVID-19

Can T-cell tests be used to determine whether people have had COVID-19? Scientists at Uppsala University and Karolinska Institutet have jointly analysed this issue under the aegis of the COMMUNITY study at Danderyd Hospital. Their study is published in the scientific journal PLOS ONE.

4 Oct 2021

Research highlights how support services have helped sexual abuse survivors during the pandemic

The impact of the Covid-19 pandemic on sexual abuse survivors going through the criminal justice system has been 'huge' with support services reporting referral increases of up to 366 per cent.

4 Oct 2021

Convalescent plasma is "futile" as COVID-19 treatment for critically ill patients, trial shows

In the earliest days of the COVID-19 pandemic, the medical community turned to a century-old treatment: Take blood from recovered patients and give it to the sick.

4 Oct 2021

Fully vaccinated people with prior SARS-CoV-2 infection have more memory B cells, study shows

A new study by University of Minnesota Medical School researchers is revealing that some people who received an mRNA vaccination for COVID-19 have greater immune responses compared to others.

4 Oct 2021

New campaign launched to help adults improve their mental wellbeing

The general public is urged to find "what works for me" to support their mental wellbeing as the Office for Health Improvement and Disparities (OHID) launches the latest  Better Health - Every Mind Matters (EMM) campaign.

4 Oct 2021

Moderna's COVID-19 vaccine proves effective against multiple SARS-CoV-2 variants, including delta

Researchers in the United States have demonstrated the real-world effectiveness of Moderna’s mRNA-1273 vaccine at protecting against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and preventing hospitalization due to coronavirus disease 2019 (COVID-19).

4 Oct 2021

Study looks at immunosuppressants and COVID vaccine efficacy

Researchers investigate the effects of five established immunosuppressant medications following COVID-19 vaccination.

4 Oct 2021

covid 19 News and Research

Anti-CD20 therapy patients can develop immune responses after SARS-CoV-2 vaccination

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

How accurate is COVID-19 modeling?

The pandemic forced my transgender wife to fight our insurer over hormones

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Study suggests shingles vaccine reduces the risk for COVID-19

Inflammatory molecules "trapped" inside micro clots may be the cause of Long COVID symptoms

Study assesses Texas nurses' COVID-19 vaccination status, intention, and hesitancy

UD chemical engineer aims to improve the delivery of therapeutic medicines to the body

New study underscores the importance of improving COVID-19 vaccination rates worldwide

SARS-CoV-2 mRNA vaccines elicit higher levels of antibodies compared to natural infection

Is gout a risk factor for COVID-19?

What makes SARS-CoV-2 variants more virulent?

Scientists analyze if T-cell tests can be used to determine whether people had COVID-19

Research highlights how support services have helped sexual abuse survivors during the pandemic

Convalescent plasma is "futile" as COVID-19 treatment for critically ill patients, trial shows

Fully vaccinated people with prior SARS-CoV-2 infection have more memory B cells, study shows

New campaign launched to help adults improve their mental wellbeing

Moderna's COVID-19 vaccine proves effective against multiple SARS-CoV-2 variants, including delta

Study looks at immunosuppressants and COVID vaccine efficacy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News